healthy male volunteers
Showing 1 - 25 of >10,000
Healthy Male Subjects Trial (tafolecimab (a modified manufacturing process), tafolecimab (a original manufacturing process))
Not yet recruiting
- Healthy Male Subjects
- tafolecimab (a modified manufacturing process)
- tafolecimab (a original manufacturing process)
- (no location specified)
Mar 29, 2023
Healthy Trial in Suzhou ([14C]Iruplinalkib (WX-0593))
Completed
- Healthy
- [14C]Iruplinalkib (WX-0593)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Feb 5, 2023
Healthy Volunteers Trial (Liposomal Amikacin for Inhalation)
Completed
- Healthy Volunteers
- Liposomal Amikacin for Inhalation
- (no location specified)
Aug 11, 2023
Alzheimer Trial in Daejeon (GB-5001A, GB-5001D, Oral cohort)
Recruiting
- Alzheimer Disease
- GB-5001A
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Nov 17, 2023
Healthy Male Volunteers Trial (HGP1607, HGP1501, HGP1607+HGP1501)
Completed
- Healthy Male Volunteers
- HGP1607
- +2 more
-
Seoul, Korea, Republic ofSeoul Asan Hospital
Nov 7, 2022
Metastatic Breast Cancer, Metastatic Gastric Cancer Trial in Changchun (Trastuzumab for injection, Herceptin)
Completed
- Metastatic Breast Cancer
- Metastatic Gastric Cancer
- Trastuzumab for injection
- Herceptin
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 1, 2023
Healthy Volunteers Trial in Seoul (Midazolam, Clarithromycin, Grapefruit juice)
Completed
- Healthy Volunteers
- Midazolam
- +2 more
-
Seoul, Korea, Republic ofSeoul National University Hospital
Oct 25, 2022
Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])
Completed
- Gastric Cancer
- +2 more
- Ramucirumab Injection
- Ramucirumab Injection [Cyramza]
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023
Weightlessness Trial in Toulouse (Dry immersion)
Not yet recruiting
- Weightlessness
- Dry immersion
-
Toulouse, FranceMedes-Imps
Aug 5, 2022
Healthy Trial in Antwerpen (BI 655088, Placebo)
Completed
- Healthy
- BI 655088
- Placebo
-
Edegem, BelgiumSGS Life Science Services - Clinical Research
Apr 20, 2022
Healthy Trial in Jeonju (HCP2201, RLD2205, RLD2206)
Not yet recruiting
- Healthy
- HCP2201
- +2 more
-
Jeonju, Jeollabuk-do, Korea, Republic ofChonbuk National University Hospital
Feb 10, 2023
Healthy Volunteers Trial in Newark (Bmab 1000, Prolia®)
Recruiting
- Healthy Volunteers
- Bmab 1000
- Prolia®
-
Newark, New JerseyBiotrial Inc
Apr 12, 2022
Healthy Trial in Groningen (BI 764198 (C-14) (approach 1), BI 764198 (C-14) (approach 2))
Recruiting
- Healthy
- BI 764198 (C-14) (approach 1)
- BI 764198 (C-14) (approach 2)
-
Groningen, NetherlandsICON
May 8, 2023
Breast Cancer Trial in Berlin (420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection, Perjeta (EU origin) 420 mg in 14 mL
Recruiting
- Breast Cancer
- 420 mg EG1206A EirGenix Pertuzumab in 14 mL Injection
- +2 more
-
Berlin, GermanyCRS Clinical Research Services Berlin GmbH
Jul 20, 2022
Hematologic Malignancy, Solid Tumor, Fibrosis Trial in Seoul (Ivaltinostat, Placebo)
Not yet recruiting
- Hematologic Malignancy
- +2 more
- Ivaltinostat
- Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Feb 6, 2023
Granulomatosis With Polyangiitis, Hemophagocytic Syndrome Trial in Changchun (Meperizumab injection, NUCALA®)
Not yet recruiting
- Granulomatosis With Polyangiitis
- Hemophagocytic Syndrome
- Meperizumab injection
- NUCALA®
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 28, 2022
Healthy Male Volunteers Trial in Paris, Saint-Herblain (NUTRIOSE®, GLUCIDEX® IT21 (Placebo))
Recruiting
- Healthy Male Volunteers
- NUTRIOSE®
- GLUCIDEX® IT21 (Placebo)
-
Paris, France
- +1 more
Nov 16, 2022
Healthy Trial in Mumbai (Risperidone, Mifepristone, Risperidone-matched )
Completed
- Healthy
- Risperidone
- +3 more
-
Mumbai, IndiaDhirubhai Ambani Life Sciences Centre
Feb 4, 2022
Healthy Trial in Liège (Ir-CPI - Dose 1, Ir-CPI - Dose 2, Ir-CPI - Dose 3)
Active, not recruiting
- Healthy
- Ir-CPI - Dose 1
- +4 more
-
Liège, BelgiumA.T.C. Pharma
Jul 19, 2022
Healthy Trial in Zuidlaren (MYL-1402O, US marketed Avastin(R), EU marketed Avastin(R))
Completed
- Healthy
- MYL-1402O
- +2 more
-
Zuidlaren, NetherlandsPRA Health Sciences - Early Development Services
Mar 9, 2022
Healthy Trial (BI 1015550, BI 1015550 mixed with [C-14]-BI 1015550)
Not yet recruiting
- Healthy
- BI 1015550
- BI 1015550 mixed with [C-14]-BI 1015550
- (no location specified)
Feb 6, 2023